Baxdela

FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise
Seeking Alpha
Fri, 10/25/19 - 10:37 am
Melinta Therapeutics
FDA
Baxdela
community-acquired bacterial pneumonia
In starved antibiotic field, Melinta soars as FDA grants speedy drug review
Endpoints
Thu, 06/20/19 - 09:53 am
Melinta Therapeutics
antibiotics
Baxdela
community-acquired bacterial pneumonia
FDA
priority review
Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic
Endpoints
Mon, 06/19/17 - 11:35 pm
Melinta Therapeutics
FDA
antibiotics
delafloxacin
Baxdela